If you are experiencing serious side effects from a medication or an injury from a defective product you should first speak with your doctor. Then contact Brent M. Cordell for a free initial consultation and case evaluation. Our attorneys also represent family members of those who died a wrongful death due to dangerous drugs or defective products.
Brent M. Cordell,
Attorney at Law
1445 North Loop West,
Suite 700 Houston, TX.77008
Voice: (713) 248-5265
email: bcordelllaw@gmail.com
Fentora is being put under the radar as the powerful narcotic pain killer has been dubbed as having potentially fatal side effects by the FDA. The FDA Public Health Advisory board has issued a warning in regards to Fentora due to reports of deaths associated with the serious side effects of the medication.
FDA states that most recent adverse events and deaths associated with use of Fentora were caused by improper patient selection, incorrect dosing, and inappropriate substitution of Fentora for other pain medications.
Fentora is intended only for treatment of "breakthrough pain" in cancer patients, meaning intense increases in pain that occur with rapid onset.
Fentora (Fentanyl Buccal Tablets )®
Cephalon, Inc., in collaboration with the U.S. Food and Drug Administration (FDA), has issued a letter in response to recently reported serious adverse events, including some deaths in patients who were not appropriate candidates for FENTORA. These events appear to have occurred as a result of improper use in patients who were not already taking opioids around-the-clock (opioid nontolerant); improper dosing of the medication; and/or improper substitution of FENTORA for other fentanyl-based medications.
FENTORA is indicated only for the management of breakthrough pain in patients with cancer who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. FENTORA must only be prescribed to patients who are routinely taking around-the-clock opioids. FENTORA should not be prescribed to patients for acute pain, postoperative pain, headache/migraine, or sports injuries. Only one tablet per episode should be taken once a dose is established and patients must wait at least four hours before taking another dose of FENTORA.
FENTORA contains fentanyl, an opioid agonist and a Schedule II controlled substance, with an abuse liability similar to other opioid analgesics. FENTORA can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing FENTORA in situations where the physician or pharmacist is concerned about an increased risk of misuse, abuse or diversion. Schedule II opioid substances which include morphine, oxycodone, hydromorphone, oxymorphone, and methadone have the highest potential for abuse and risk of fatal overdose due to respiratory depression. Because life-threatening respiratory depression could occur at any dose in opioid non-tolerant patients, FENTORA is contraindicated in the management of acute or postoperative pain. This product is not indicated for use in opioid nontolerant patients.